Date of first round report: 1 September 2016 Date of second round report: 30 January 2017



Download 5.49 Mb.
Page42/53
Date16.05.2018
Size5.49 Mb.
1   ...   38   39   40   41   42   43   44   45   ...   53

Safety questions/responses

  1. Safety clinical question 1


QUESTION 1

The sponsor is requested to provide a table which integrates from all clinical studies (referencing the source studies) and presents:

    1. the total number of patients treated to date:

  1. at the proposed dose level and regimen (palbociclib 125 md QD 3/1)

  2. 1. in combination with fulvestrant

        1. 2. in combination with letrozole at the proposed dose

        2. 3. in combination with letrozole at any dose level

  3. as monotherapy

  1. at the proposed dose and schedule

  2. at any other dose

  1. b. the median duration of treatment for all those patients and an interquartile range

  2. in combination with fulvestrant

  3. in combination with letrozole at the proposed dose

  4. in combination with letrozole at any dose level
1   ...   38   39   40   41   42   43   44   45   ...   53


The database is protected by copyright ©dentisty.org 2019
send message

    Main page